Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Journal of Translational Medicine|November 26, 2024
Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individualsKerstin Lang, Christina U Köhler, Katharina Wichert, et al.
European Urology Oncology|May 8, 2025
Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder CancerBernd J Schmitz-Dräger, Ekkehardt Bismarck, Florian Roghmann, et al.
Urologic Oncology|August 26, 2014
Mental health outcomes in elderly men with prostate cancerPraful Ravi, Pierre I Karakiewicz, Florian Roghmann, et al.
JAMA Oncology|May 9, 2024
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical TrialMarc-Oliver Grimm, Martin Schostak, Christine Barbara Grün, et al.
European Urology|April 8, 2023
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic EvolutionAlexander Cox, Niklas Klümper, Johannes Stein, et al.
Urologic Oncology|March 7, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancerNicolas von Landenberg, Atiqullah Aziz, Friedrich C von Rundstedt, et al.
Urologic Oncology|October 23, 2022
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuriaEva Charlotte Kuckuck, Jörg Hennenlotter, Tilman Todenhöfer, et al.
Urologic Oncology|February 25, 2024
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancerNatalya Benderska-Söder, Thorsten Ecke, Lisa Kleinlein, et al.
Urologic Oncology|August 3, 2020
Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on sizeKarl H Tully, Marco Moschini, Friedrich-Carl E von Rundstedt, et al.
European Geriatric Medicine|July 12, 2026
Integration of geriatric assessment-guided care plan modifications and interventions into clinical paths of older adults with cancer (GORILLA): a feasibility approachRea Sujin Mayland, Merlin Deterding, Filippo Maria Verri, et al.
Pageof 15